Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Global Shift Toward Trust: 2025 Employer Branding Creativity Awards Highlight New Talent Trends 2025-12-08 20:00
HanchorBio Presents First-in-Human Data of HCB101 Monotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma at ASH 2025 2025-12-08 20:00
51Talk Online Education Group Announces New Share Repurchase Program 2025-12-08 19:35
Huya Announces January 7, 2026 Open Beta Launch for Goose Goose Duck Mobile in Chinese Mainland 2025-12-08 19:30
51Talk Online Education Group Announces Third Quarter 2025 Results 2025-12-08 19:30
Geleximco Group and China intelligent chassis solution provider Leekr Technology signed a MoU to deepen industrial collaboration 2025-12-08 18:03
Sennics Unveils Major Breakthroughs in New Eco-Friendly Antioxidant SA6000 2025-12-08 17:01
SJTU International Gen Z Students Explore Shanghai's Innovation Ecosystem 2025-12-08 16:57
Yantai offers global bay areas a paradigm of low-carbon transformation 2025-12-08 16:52
GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.' 2025-12-08 14:36
CIMC Unveils New Global Brand Logo and Visual Identity System 2025-12-08 10:21
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting 2025-12-08 10:08
Median PFS Trending Beyond One Year: Leads Biolabs' LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting 2025-12-08 10:00
IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH 2025-12-08 09:57
ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma 2025-12-08 09:02
Global Times: Mogao Caves' mural paintings meet modern technology 2025-12-08 08:48
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting 2025-12-08 08:15
CARsgen's CAR-T Product Zevor-Cel Included in China's Commercial Health Insurance Innovative Drug Catalogue 2025-12-07 17:21
All Approved Indications of Five Akeso's Innovative Drugs Included in China's Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs 2025-12-07 14:18
Skymizerʼs HyperThought™ Wins "Best IP/Processor of the Yearˮ and "Most Promising Productˮ at EE Awards Asia 2025 2025-12-07 12:53
1 6 7 8 9 10 7007